Diabetes Trials in Falkensee, Germany
Conditions / Diabetes / Falkensee, Germany
Clinical trials for Diabetes investigate a range of treatment strategies and patient populations.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01179048 | Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results | COMPLETED | PHASE3 |
| NCT01923181 | Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes | COMPLETED | PHASE2 |
| NCT02648204 | Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes. | COMPLETED | PHASE3 |
| NCT03078478 | A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs | COMPLETED | PHASE3 |
| NCT03268005 | Research Study Comparing a New Medicine Fast-acting Insulin Aspart to Another Already Available Medicine NovoRapid/NovoLog in People With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT01720446 | Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT01664247 | The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification | COMPLETED | PHASE3 |
| NCT00518882 | Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT02607865 | Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT02692716 | A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |